New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023
CCO Oncology Podcast - Un pódcast de Clinical Care Options
Categorías:
Gain insight into expert faculty perspectives as they discuss recent key studies from EHA 2023 on BTK inhibition in chronic lymphocytic leukemia and the potential implications for clinical practice.
